About us

Nacamed is a clinical-stage biotechnology company dedicated to the discovery and development of nanosystems for drug delivery, controlled hydrogen delivery and diagnostic purposes.

Nacamed is a Norwegian spin-off company of Dynatec AS. Dynatec has through the 10 last years investigated in the production of Silicon particles, and has acquired unique competency.
Nacamed aims is to combine these physical competencies with the clinical competencies in the pharmaceutical industry to create a new generation of treatment methods.